Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Multi-omics analysis indicates an association between TAPBP and prostate cancer
Xinlong Wang1,2, Aimin Jiang2, Chao Li1
1Department of Urology, The Third Xiangya Hospital of Central South University, Changsha, China.
Abstract:
Prostate cancer is one of the most common malignant tumors among men worldwide, and surgery remains its mainstay of treatment. It is unclear how prostate cancer develops and what the most effective drug targets are for treating prostate cancer. Therefore, we sought to identify the genes responsible for prostate cancer. By integrating multidimensional and high-throughput data, proteome wide association studies (PWAS), transcriptome wide association studies (TWAS), single-cell sequencing, functional enrichment, Mendelian randomization (MR), and Bayesian co-localization analyses were used to screen for candidate genes that may contribute to prostate cancer and associate with clinical results of prostate cancer. Our comprehensive analysis showed that protein abundance of eight genes was associated with prostate cancer, four of which were validated at the transcriptome level. These 8 candidate genes (MSMB, PLG, CHMP2B, ATF6B, EGF, TAPBP, GAS1 and MMP7) were validated. After combining single-cell sequencing, Mendelian randomization, and Bayesian co-localization analyses, we identified 1 gene (TAPBP) that is strongly associated with prostate cancer.
Insights
Researchers identified genes linked to prostate cancer development and treatment. The study pinpointed TAPBP as a key gene strongly associated with prostate cancer, offering potential new therapeutic targets.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Prostate cancer is a prevalent malignancy in men globally, with surgery as the primary treatment.
- The underlying mechanisms of prostate cancer development and effective drug targets remain incompletely understood.
Purpose of the Study:
- To identify genes contributing to prostate cancer development.
- To discover potential therapeutic targets for prostate cancer treatment.
Main Methods:
- Integrated multidimensional and high-throughput data, including proteome-wide association studies (PWAS) and transcriptome-wide association studies (TWAS).
- Employed single-cell sequencing, functional enrichment, Mendelian randomization (MR), and Bayesian co-localization analyses.
- Screened for candidate genes associated with prostate cancer and clinical outcomes.
Main Results:
- Identified eight candidate genes with protein abundance associated with prostate cancer.
- Validated four of these genes at the transcriptome level.
- Through integrated analyses, pinpointed TAPBP as a single gene strongly associated with prostate cancer.
Conclusions:
- The study identified eight validated candidate genes, including MSMB, PLG, CHMP2B, ATF6B, EGF, TAPBP, GAS1, and MMP7.
- TAPBP emerged as a significant gene strongly linked to prostate cancer through advanced bioinformatic analyses.
- Findings provide potential targets for future prostate cancer research and therapeutic strategies.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

